Related Experiment Video
Updated: May 19, 2026
07:23
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Functionally selective AT(1) receptor activation reduces ischemia reperfusion injury
Anders Hostrup1, Gitte Lund Christensen, Bo Hjort Bentzen
1Danish Arrhythmia Research Centre, Department of Biomedical Sciences, Faculty of Health, University of Copenhagen, Copenhagen, Denmark.
Summary
Preconditioning rat hearts with a specific Angiotensin II (AngII) peptide, [SII]AngII, significantly reduced heart damage from ischemia-reperfusion injury by activating AT(1) receptors.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
- Molecular Biology
Background:
- Angiotensin II (AngII) is crucial for cardiovascular homeostasis.
- AngII binds to AT(1) and AT(2) receptors, with AT(1)R (a GPCR) mediating most AngII functions.
- AT(1)R signaling involves both G protein-dependent and independent pathways, separable by biased agonists.
Purpose of the Study:
- To investigate the effects of AngII and a β-arrestin biased agonist ([SII]AngII) on myocardial ischemia-reperfusion injury.
- To explore the role of distinct AT(1)R signaling pathways in cardioprotection.
Main Methods:
- Utilized isolated rat hearts in a Langendorff perfusion system.
- Administered AngII and [SII]AngII for preconditioning and postconditioning protocols.
- Assessed infarct size following global ischemia and reperfusion.
Main Results:
- Preconditioning with [SII]AngII significantly reduced infarct size (from 46±8.4% to 22±3.4%).
- Neither AngII preconditioning nor AngII or [SII]AngII postconditioning showed a protective effect.
- Demonstrated that selective AT(1)R signaling modulation impacts cardiac injury.
Conclusions:
- Simultaneous blockade of G protein signaling and activation of G protein-independent signaling via AT(1) receptors confers cardioprotection.
- [SII]AngII, a β-arrestin biased agonist, exhibits a protective effect against ischemia-reperfusion injury.
- Targeting specific AT(1)R signaling pathways offers a potential therapeutic strategy for myocardial protection.
Related Concept Videos
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:30Spare Receptors
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
01:25Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.